Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **fungal cell wall** is a multi-layered extracellular structure essential for fungal survival and pathogenicity. It is composed primarily of polysaccharides, including **chitin**, **β-glucans** (mainly β-1,3 and β-1,6 linkages), **mannoproteins**, and sometimes **melanin** in certain species. The wall is structurally organized as follows: an innermost rigid scaffold of chitin and β-glucan, a middle meshwork of glucan branches, and an outer layer rich in mannoproteins. The **fungal cell membrane** is located underneath the cell wall and features unique lipids such as **ergosterol**, which is absent in animal cells. Both the cell wall and membrane provide physical protection, regulate osmotic pressure, and modulate interactions with hosts and the environment. They are **not found in mammalian cells**, making them prime drug targets. Many antifungal drugs either inhibit the synthesis of key components (like β-1,3-glucan and ergosterol) or directly disrupt the integrity of these barriers, resulting in cell death. Notably, these structures are also implicated in antifungal resistance mechanisms, with changes in composition contributing to the reduced efficacy of common therapies. Despite their importance as drug targets, the fungal cell wall and membrane are **not single, canonical receptors or proteins** but rather complex, multi-molecular structures with numerous subcomponents, each potentially serving as a more specific drug target (e.g., β-1,3-glucan synthase, chitin synthase). Monitoring components such as β-1,3-D-glucan in serum and chitin levels can serve as biomarkers for infection and treatment response. Therapeutic challenges include the emergence of drug resistance, restricted tissue penetration, and host toxicity for certain agents.
Inhibition of β-1,3-glucan synthase (echinocandins) Disruption of ergosterol synthesis and membrane integrity (azoles, polyenes) Inhibition of chitin synthase (experimental) Direct disruption/permeabilisation of fungal membranes (PHMB, amphotericin B)
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fungal cell wall and Fungal cell membrane.